GAMBARO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 11.409
AS - Asia 8.911
EU - Europa 8.607
SA - Sud America 1.359
AF - Africa 148
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 5
Totale 30.473
Nazione #
US - Stati Uniti d'America 11.278
SG - Singapore 4.167
CN - Cina 2.651
GB - Regno Unito 1.990
RU - Federazione Russa 1.198
BR - Brasile 1.173
FR - Francia 1.099
IE - Irlanda 1.081
HK - Hong Kong 1.057
IT - Italia 806
SE - Svezia 703
DE - Germania 643
FI - Finlandia 473
UA - Ucraina 339
VN - Vietnam 273
KR - Corea 251
IN - India 79
AR - Argentina 69
CA - Canada 63
JP - Giappone 59
TR - Turchia 48
ID - Indonesia 43
NL - Olanda 42
BD - Bangladesh 41
BE - Belgio 40
PK - Pakistan 39
AT - Austria 38
EC - Ecuador 37
MX - Messico 36
TG - Togo 33
ZA - Sudafrica 33
IQ - Iraq 27
AU - Australia 26
ES - Italia 25
IL - Israele 22
VE - Venezuela 22
UZ - Uzbekistan 20
MA - Marocco 19
PL - Polonia 19
CL - Cile 17
CO - Colombia 16
CH - Svizzera 13
GR - Grecia 13
AE - Emirati Arabi Uniti 11
DZ - Algeria 11
JO - Giordania 11
TN - Tunisia 11
AZ - Azerbaigian 10
IR - Iran 10
RO - Romania 10
CZ - Repubblica Ceca 9
KE - Kenya 9
SK - Slovacchia (Repubblica Slovacca) 9
EG - Egitto 8
KZ - Kazakistan 8
LB - Libano 8
PH - Filippine 8
KG - Kirghizistan 7
NO - Norvegia 7
PY - Paraguay 7
UY - Uruguay 7
AL - Albania 6
BG - Bulgaria 6
HR - Croazia 6
NP - Nepal 6
PE - Perù 6
TW - Taiwan 6
BH - Bahrain 5
BY - Bielorussia 5
DK - Danimarca 5
HN - Honduras 5
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
TH - Thailandia 5
CR - Costa Rica 4
EU - Europa 4
GE - Georgia 4
GT - Guatemala 4
LA - Repubblica Popolare Democratica del Laos 4
OM - Oman 4
PS - Palestinian Territory 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
EE - Estonia 3
JM - Giamaica 3
LT - Lituania 3
MY - Malesia 3
PR - Porto Rico 3
SN - Senegal 3
SV - El Salvador 3
CY - Cipro 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
LK - Sri Lanka 2
MK - Macedonia 2
Totale 30.434
Città #
Jacksonville 2.017
Singapore 1.977
Southend 1.757
Chandler 1.325
Dallas 1.187
Dublin 1.078
Hong Kong 1.050
Woodbridge 754
Ashburn 727
Houston 473
Beijing 448
Princeton 418
Lawrence 417
Ann Arbor 405
Wilmington 371
Jinan 220
Nanjing 177
New York 158
Verona 156
Shenyang 152
Columbus 144
The Dalles 144
Sindelfingen 136
Hebei 113
Helsinki 93
Redmond 93
São Paulo 92
Tianjin 92
Seattle 90
Los Angeles 88
Milan 87
Ho Chi Minh City 84
Nanchang 72
Changsha 69
Buffalo 68
Zhengzhou 67
Munich 65
Guangzhou 62
Ningbo 62
Boardman 60
Haikou 60
Norwalk 58
Santa Clara 57
Tokyo 54
Taizhou 52
Taiyuan 45
Hanoi 44
Nuremberg 44
Jiaxing 43
Redwood City 42
Brussels 40
Fairfield 38
Council Bluffs 37
Rio de Janeiro 37
Hangzhou 36
San Francisco 35
Turku 35
Lomé 33
London 33
Chicago 30
Lanzhou 28
Dong Ket 25
Dongguan 25
Lancaster 25
Moscow 25
Fuzhou 24
Falls Church 23
Frankfurt am Main 23
Jakarta 23
Belo Horizonte 22
Brasília 22
Brooklyn 22
Lappeenranta 22
Bologna 21
Shanghai 20
Toronto 20
Vienna 20
Washington 20
Kent 19
Martellago 19
Phoenix 19
Seoul 19
Shenzhen 19
Tashkent 19
Amsterdam 18
San Diego 18
Curitiba 17
Mianwali 17
Hyderabad 16
Montreal 16
Boston 14
Chennai 14
Florence 14
Porto Alegre 14
Ribeirão Preto 14
Tappahannock 14
Warsaw 14
Atlanta 13
Genova 13
Istanbul 13
Totale 18.664
Nome #
Common Variants Associated to Type 2 Diabetes in the Italian Population 413
Placche di Randall e calcolosi ossalo-calcica idiopatica: quale ruolo e quale futuro? 218
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 193
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 191
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans. 170
Age dependence of within-subject biological variation of nine common clinical chemistry analytes 152
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 140
Sulodexide and glycosaminoglycans in the progression of renal disease. 131
Placche di Randal e calcolosi ossalocalcica idiopatica: quale ruolo e quale futuro? 128
mTOR inhibitors and renal allograft: Yin and Yang. 128
An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. 126
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 125
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 125
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 124
Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? 123
A critical evaluation of the urinary inhibiting activity in idiopathic calcium oxalate nephrolithiasis. 122
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. 119
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. 118
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 118
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 118
[Abnormalities in the erythrocyte membrane transport of oxalate in calcium oxalate lithogenesis]. 118
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 116
ENDOTHELIAL PROGENITOR CELLS IN ACUTE RENAL INJURY 115
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 113
The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. 112
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 112
Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study. 111
LIVER-KIDNEY-TRANSPLANTATION IN TYPE 1 PRIMARY HYPEROXALURIA: DESCRIPTION AND COMMENTS ON A CASE. 110
High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. 110
A validated model of disease progression in IgA nephropathy. 109
Detection of a large deletion in the P-selectin (SELP) gene 109
Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): A Padua Medical School discovery in the 1930s. 108
Unusual renal presentation of Fabry disease in a female patient. 108
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 108
A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling 108
Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment. 107
QUANTITATION OF TGF-BETA1 mRNA IN PORCINE MESANGIAL CELLS BY COMPARATIVE KINETIC RT/PCR: COMPARISON WITH RIBONUCLEASE PROTECTION ASSAY AND IN SITU HYBRIDIZATION. 107
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. 106
ADVANCES IN REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION ANALYSIS OF CELLULAR mRNA LEVELS OF TRANSFORMING GROWTH FACTOR-BETA1 BY CAPILLARY ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE DETECTION. 106
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. 106
La qualità della vita nell’anziano in dialisi [Quality of life of the elderly patient on dialysis]. 105
Does Randall’s plaque represent a necessary condition in the pathogenesis of the idiopathic calcium oxalate stones? 104
Primary IgA nephropathy is more severe in TGF-ss1 high secretor patients 103
Directional dominance on stature and cognition in diverse human populations. 103
A genome-wide association study of anorexia nervosa 103
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 103
Renin-angiotensin system (RAS) DNA polymorphisms and TGFbeta1-mediated fibrogenetic pathway gene expression studies in primary IgA naphropathy (Berger’s disease). 102
Bone Disease in Medullary Sponge Kidney and Effect of Potassium Citrate Treatment. 102
GDNF gene Variants Associated with Medullary Sponge Kidney. Distinguish a Specific Clinical Phenotype. 102
Genome-wide association studies identify genetic loci associated with albuminuria in diabetes. 102
Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders 102
Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients. 101
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 100
[Physical, chemical and morphological urine examination guidelines for the Analytical Phase from the Intersociety Urinalysis Group] 100
Donor-transmitted cancer in kidney transplant recipients: a systematic review 100
Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population. 99
Randall's plaque, calcium-sensing receptor, and idiopathic calcium nephrolithiasis 99
Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study 99
[In search of renal stem cells] 98
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 98
Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation. 97
Dietary fatty acid supplementation modulates the urinary excretion of calcium and oxalate in the rat. Insight into calcium lithogenesis. 97
Henoch-Schonlein purpura and Crohn's disease in a family. 97
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 97
New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. 97
SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function 97
Glycosaminoglycan therapy for long-term diabetic complications? 96
General practitioners' serum creatinine recording styles. 96
Heparanase as a target in cancer therapy. 96
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 96
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 96
Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits 96
Medullary sponge kidney: state of the art. 95
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 95
The Role of prEoperative ultraSonography on patenCy of native arteriovenoUs accEss: RESCUE Study (in press) 94
[Dent's disease: hereditary nephrolithiasis related to defective tubular endocytosis processes] 94
Invecchiamento e funzionalità renale: indagine prospettica in una coorte di soggetti anziani in buone condizioni di salute 94
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 94
A Delphi consensus panel on nutritional therapy in chronic kidney disease 94
Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. 93
Inhibition of transforming growth factor-beta 1 gene overexpression as a strategy to prevent fibrosis. 93
Mild tubular damage induces calcium oxalate crystalluria in a model of subtle hyperoxaluria: Evidence that a second hit is necessary for renal lithogenesis. 93
Small effective population size and genetic homogeneity in the Val Borbera isolate 92
Call for prospective studies of cystatin C. 92
ABNORMAL ARACHIDONIC ACID CONTENT OF MEMBRANE PHOSPHOLIPIDS- THE UNIFYING HYPOTHESIS FOR THE GENESIS OF HYPERCALCIURIA AND HYPEROXALURIA IN IDIOPATHIC CALCIUM NEPHROLITHIASIS. 92
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 92
Predictive model for delayed graft function based on easily available pre-renal transplant variables 92
Modulation of genetic associations with serum urate levels by body-mass-index in humans. 92
How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network 92
[Gout and kidney during XVII and XIX centuries] 91
Silent chronic kidney disease epidemic seen from Europe: designing strategies for clinical management of the early stages. 91
Lithiasis in cystic kidney disease and malformations of the urinary tract. 91
Placche di Randall, familiarità per calcolosi e numerosità di eventi litiasici: esiste una correlazione ? 91
[Role of Tamm-Horsfall mucoprotein in calcium oxalate lithogenesis]. 91
The Genetics of Kidney Stones 89
Crystals, Randall's plaques and renal stones: do bone and atherosclerosis teach us something? 88
GLYCOSAMINOGLYCAN PREVENTS HYPERGLYCEMIA-INDUCED RENAL TGF-BETA 1 GENE EXPRESSION. 88
Association studies of genetic polymorphisms and complex disease. 87
Economic Evaluation of Ferric Carboxymaltose for the Management of Hemodialysis Patients with Iron Deficiency Anemia in Italy 87
LOW-MOLECULAR-WEIGHT HEPARIN PREVENTS HIGH GLUCOSE- AND PHORBOL ESTER-INDUCED TGF-BETA 1 GENE ACTIVATION. 86
Totale 11.027
Categoria #
all - tutte 135.860
article - articoli 127.540
book - libri 0
conference - conferenze 4.145
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.175
Totale 271.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.082 0 0 65 320 377 376 35 203 161 32 372 141
2021/20222.210 109 498 12 194 75 27 38 187 107 113 138 712
2022/20234.960 494 381 676 609 536 1.278 27 277 445 30 138 69
2023/20242.874 105 226 247 232 277 404 73 559 27 90 386 248
2024/20257.903 481 577 277 1.295 324 190 354 442 1.181 514 594 1.674
2025/20264.149 1.620 1.391 1.138 0 0 0 0 0 0 0 0 0
Totale 31.087